No Data
No Data
Is Weakness In Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Kelun Pharmaceutical Gives Windward Bio Worldwide Commercial Rights for Anti-thymic Drug
Kelun Pharma Gets Nod for Luqubopa Tablets' Registration
Sichuan Kelun Pharmaceutical Gets Acceptance for New Drug Application for Breast Cancer Drug; Shares Down 3%
Sichuan Kelun Pharmaceutical Unit Secures Approval for Tagolizumab Antibody
Sichuan Kelun Pharmaceutical (SZSE:002422) Has A Rock Solid Balance Sheet